Allergy/Intolerance Procedure
|
|
- Michael Boyd
- 5 years ago
- Views:
Transcription
1 Subject/Title Approving Authority: Keith Dewar Allergy/Intolerance Procedure Classification: Patient Rights, Safety and Protection Contact for Interpretation: Documentation Coordinator - Clinical Quality and Professional Practice Source Manual: Reference Number: Effective Date: Nov 13 th, 2017 Revision Dates: See Related Policy Allergy Record refers to: Allergy/Intolerance Record (RQHR 1455) See Appendix A NOTE: The red sleeve is a red, plastic page protector placed at the front of a person s health record so that the health care team can quickly locate and identify allergy/intolerance documents. All copies of the following documents are to be stored in the red sleeve with the most current copy of each at the front of the red sleeve. Allergy/Intolerance Record (see Appendix A) Allergy/Intolerance Changes (see Appendix B) The Allergy/Intolerance Record is a permanent part of the person s health record and remains at the front of the active chart while the person is receiving care from the Regina Qu Appelle Health Region (RQHR) health care team. On discharge, the contents from the red sleeve are filed intact at the front of the discharged health record. Procedure 1. Obtain the allergy/intolerance history and document on the Allergy Record, from the following sources as applicable: Patient Family member Friend Medical Alert ( e.g. bracelet or necklace) Pharmacy resources Previous patient record Medication Administration Record (MAR) from previous facility 2. Each allergy/intolerance documented will include allergy/intolerance type and reaction details.
2 3. If the patient s allergy/intolerance history is unobtainable, document in the unable to obtain section of the Allergy Record. The allergy/intolerance status must be reviewed daily until the allergy history is verified. 4. Allergies/intolerances will be documented in Sunrise Clinical Manager (SCM) Facility Board or Procura where available. 5. The completed Allergy Record will be immediately faxed to pharmacy and allergies/intolerances will be communicated to appropriate departments. 6. The patient s allergy/intolerance history will be reviewed prior to prescribing, dispensing or administering any medications or non-medications (i.e. latex or food). Exception: In emergency situations, urgent or stat medications may be administered without a completed allergy/intolerance history. 7. Document See Allergy Record in the section(s) of all other documents in the patient s chart that have a prompt for documenting allergy information. 8. A visual cue shall be used to identify all patients with allergies/intolerances. The allergies/intolerances are not required to be written on the visual cue. Red arm bands will be the visual cue for patients where patient identification bands are utilized. Red allergy stickers will be the visual cue for patients where patient identification bands are not utilized. A red allergy sticker will be applied to the outside of the chart where the patient identification label is (either front or spine of chart). 9. The Neonatal Intensive Care Unit (NICU) will only use the Allergy Record as needed. All newborns are considered no known allergies unless proven otherwise. 10. The Mother Baby Unit (MBU) will use the Allergy Record for mothers but only as needed for newborns. All newborns are considered no known allergies unless proven otherwise. 11. Notify any other departments or units which require allergy/intolerance information: Environmental Services regarding patient allergies to cleaning substances Nutrition and Food Services regarding food allergies (SCM Facility Board) Medical Imaging regarding allergies related to contrast medium Other care providers as needed Page 2 of 5
3 12. Allergy/intolerance information shall be kept current and be retained as a permanent part of the health record. 13. If an allergy or intolerance is identified after admission: The allergy or intolerance is added to the Allergy Record. Changes are communicated to all appropriate departments. Update visual cues (if applicable). 14. If an allergy or intolerance is found to be invalid: Removal of a medication allergy/intolerance from the Allergy Record requires a physician order. Removal of a food allergy/intolerance from the Allergy Record requires a dietitian or physician order. Update the Allergy Record by drawing a single line through the incorrect allergy/intolerance, mark void, your initials and date. Document rationale for change on the Allergy/Intolerance Changes section on the back of the Allergy Record. Changes are communicated to all appropriate departments. Update visual cues (if applicable). 15. When a patient is transferred to another health care facility/service, the Allergy Record is copied and sent with the patient to the receiving care provider. 16. When the patient is discharged to the community, a copy of the Allergy Record is given to the patient with the suggestion to provide a copy of it to other health care providers (e.g. family physician, pharmacist, nurse practitioner, etc.) so that all records will remain current. 17. Upon discharge, the contents from the red sleeve are filed intact at the front of the discharged health record and the red sleeve remains on the unit for reuse. References: This procedure was adapted with permission from Saskatoon Health Region Procedure # (July, 2013). Page 3 of 5
4 Appendix A Page 4 of 5
5 Appendix B ALLERGY/INTOLERANCE CHANGES Addressograph DATE ALLERGY/INTOLERANCE RATIONALE FOR CHANGE INITIAL CHANGES MUST BE RE-FAXED TO PHARMAY AND RE-ENTERED IN SCM OR PROCURA Adapted with Permission from the Saskatoon Health Region Page 5 of 5
Blood & Blood Product Administration
Approved by: Blood & Blood Product Administration Addendum to: Corporate Policy VII-B-397 Transfusion of Blood Components and Products- Pediatric/Neonate Gail Cameron Senior Director Operations, Maternal,
More informationNova Scotia Drug Information System
Nova Scotia Drug Information System Functions Presentation Details: Slides: 19 Duration: 00:32:04 Filename: DIS Module4.Functions.ppt Presenter Details: Slide 1 Nova Scotia Drug Information System Duration:
More informationPROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE
PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE BRIEF OUTLINE OF THIS PROCEDURE This procedure sets out the requirements for prescribing,
More informationIntroduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)
Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Introduction This guideline is designed to provide a framework for patients to administer
More informationSECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
More informationInfluenza Immunization screening is completed within the Admission Navigator of the patient s chart.
Influenza Vaccine Screening 2016-2017 one patient, one record, one system Admission Navigator Influenza Immunization screening is completed within the Admission Navigator of the patient s chart. There
More informationIEHP Healthy Kids Benefit Manual 07/15 N-100.1
Revised: August 2007 Approval: Newborn Child Coverage Benefit Coverage Newborn examinations and nursery care are covered while the mother is hospitalized. Examples of Covered Benefits 1. Medically necessary
More informationHepatitis B Positive: Care of Mother Policy
Document ID: MATY031 Version: 1.0 Facilitated by: Jo McMullan, CMM Issue Date: July 2012 Approved by: Maternity Quality Committee Review date: October 2016 Hepatitis B Positive: Care of Mother Policy Purpose
More informationHepatitis B Positive: Care of Mother Policy
Document ID: MATY031 Version: 1.0 Facilitated by: Jo McMullan, CMM Last reviewed: October 2014 Approved by: Maternity Quality Committee Review date: October 2016 Hepatitis B Positive: Care of Mother Policy
More informationNewfoundland and Labrador Pharmacy Board Standards of Practice
Newfoundland and Labrador Pharmacy Board Standards of Practice Standards for the Safe and Effective Administration of Drug Therapy by Inhalation or Injection June 2015 Table of Contents 1) Introduction...
More informationDRUG ORDERING & DISPENSING:
STUDY DRUG: List the study drugs that will be used at your site based on your hospital formulary 1. Insulin Humulin R 2. Insulin Humalog 3. Insulin Lantus DRUG SUPPLY & STORAGE: Since study drugs are not
More informationOklahoma. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationDispensing and administration of emergency opioid antagonist without a
68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies
More informationSANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery
Section Sub-section Policy Policy# Pharmacy SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Pyxis MedStation Controlled Substances 17.102 Page 11 of 5 Programmatic
More informationAbbott PXP Glucose Meters Resource: Lin Gustafson, MT(ASCP) Point of Care Coordinator, Laboratory
Abbott PXP Glucose Meters 2015 Resource: Lin Gustafson, MT(ASCP) Point of Care Coordinator, Laboratory Objectives After you complete this Computer-Based Learning (CBL) module, you should be able to: Explain
More informationPART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)
1305.16 1305.16 Special procedure for filling certain order forms. (a) The purchaser of carfentanil etorphine hydrochloride or diprenorphine shall submit copy 1 and 2 of the order form to the supplier
More informationPrescribing and Dispensing Drugs
STANDARDS & GUIDELINES Prescribing and Dispensing Drugs TABLE OF CONTENTS Standards and guidelines inform practitioners and the public of CDSBC s expectations for registrants. This document primarily contains
More informationDocument ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy
Document ref. no: Trust Policy and Procedure PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy For use in: For use by: For use for: Document owner: Status: All Clinical Areas
More informationADMINISTRATION OF INSULIN
STANDARD OPERATING PROCEDURE ADMINISTRATION OF INSULIN Issue History First issued April 2012 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote the safe administration
More informationLong Term Care Respiratory Outbreak Worksheet Edmonton Zone
Long Term Care Respiratory Outbreak Worksheet Edmonton Zone Page 1 This worksheet is provided as an optional tool for use during respiratory outbreaks in Long Term Care facilities in Edmonton Zone. This
More informationImproving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies
Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Leigh Briscoe-Dwyer, PharmD, BCPS, FASHP Chief Pharmacy and Medication Safety Officer North Shore Long Island Jewish Health
More information5 DAY SUPPLY LIMIT OF PRESCRIPTION OPIOID MEDICATIONS
5 DAY SUPPLY LIMIT OF PRESCRIPTION OPIOID MEDICATIONS 1. Members under the age of 18: a. Except as otherwise specified in Section (1)(b), Conditions and Care Exclusion from the 5 day Supply Limitation
More informationSARASOTA MEMORIAL HOSPITAL POLICY
PS1070 SARASOTA MEMORIAL HOSPITAL POLICY TITLE: BREAST MILK EXPOSURE POLICY #: EFFECTIVE DATE: REVIEWED/REVISED DATE: POLICY TYPE: 5/23/06 06/15/18 Clinical Non-Clinical 1 of 11 Job Title of Responsible
More informationROYAL UNIVERSITY HOSPITAL Number: 1300 Saskatoon, Saskatchewan Date: Oct 2016 Maternal Services Policy and Procedure Manual Date: April 2010
ROYAL UNIVERSITY HOSPITAL Number: 1300 Saskatoon, Saskatchewan Date: Oct 2016 Maternal Services Policy and Procedure Manual Previous Date: April 2010 Leanne Smith Director, Maternal Services Issuing Authority
More informationNewborn Screening: Train the Trainer PPT Questions
Newborn Screening: Train the Trainer PPT Questions Bloodspot Screening Purpose 1. How many possible hidden disorders does the Oklahoma Newborn Screening Program screen for? A. >10 B. >20 C. >30 D. >40
More informationOBSTETRIC THEATRE GUIDELINE FOR WOMEN WITH LATEX ALLERGY (PRINCESS OF WALES HOSPITAL SITE) Approval date: 15 th November 2018
OBSTETRIC THEATRE GUIDELINE FOR WOMEN WITH LATEX ALLERGY (PRINCESS OF WALES HOSPITAL SITE) Speciality: Approval body: Maternity Approval date: 15 th November 2018 Date of Review: 15 th November 2021 Obstetric
More informationMETHADONE PROGRAM ANNUAL REPORT 2012 AND BUSINESS PLAN 2013
METHADONE PROGRAM ANNUAL REPORT 2012 AND BUSINESS PLAN 2013 May 2013 P a g e 2 Table of Contents ANNUAL REPORT 2012... 3 BUSINESS PLAN 2013... 6 APPENDICES A - Methadone Monthly Patient Statistics 2012...
More informationPolicy for the safe use of oral methotrexate
Policy for the safe use of oral methotrexate Policy Checklist Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Does this meet criteria of a Policy? Staff side
More informationPOLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011
POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE September 2011 WHSCT Policy for the safe use of oral methotrexate in secondary care Page 1 of 8 Policy Title Policy for the safe use of oral
More informationDear Parent or Guardian,
Dear Parent or Guardian, This summer may be a period of transition for you and your child. For a lot of our students it may even be the first time they are taking the lead in their personal care, including
More informationIMPAACT MOCHA More Options for Children and Adolescents
IMPAACT 2017 Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed
More informationThe Lee Wiggins Childcare Centre ALLERGY AND ANAPHYLAXIS POLICY. Purpose:
Purpose: To provide guidelines to create a safe environment for children with severe allergies or anaphylactic reactions at the Lee Wiggins Childcare Centre and to ensure compliance with the Child Care
More informationKey Findings from the ISMP Canada Safety Bulletins Drugs: Oversight, Safety and Supply OHA Educational Event November 20, 2015 Toronto, ON
Key Findings from the ISMP Canada Safety Bulletins Drugs: Oversight, Safety and Supply OHA Educational Event November 20, 2015 Toronto, ON David U President & CEO ISMP Canada Ontario Critical Incident
More informationCARE OF HEPATITIS B POSITIVE MOTHER
CARE OF HEPATITIS B POSITIVE MOTHER SCOPE All medical and midwifery staff employed by Hutt Valley DHB. All Hutt Valley DHB Maternity access holders. All Special Care Baby Unit staff PURPOSE The purpose
More informationPrevention And Management Of Latex Sensitisation And Allergy For Patients
Prevention And Management Of Latex Sensitisation And Allergy For Patients Contents Policy... 1 Purpose... 1 Scope/Audience... 1 Associated documents... 1 Latex Free Guides... 2 Management of Patient with
More informationPolicy and Procedure Manual
Policy and Procedure Manual Medication Management MM.3-6 SUBJECT/TITLE: PURPOSE: DEFINITION: ADULT, INPATIENT PNEUMOCOCCAL AND SEASONAL INFLUENZA VACCINATION To ensure that adult inpatients who are candidates
More informationMulti-Diagnostic Services, Inc.
Multi-Diagnostic Services, Inc. 139-16 91st Avenue Jamaica, New York 11435 718 454-8556 Fax: 718 454-7950 Name: Date of Appointment: AM Time: PM What to Expect and How to Prepare for the Mammography Screening
More informationIMPORTANT HEALTH INFORMATION
IMPORTANT HEALTH INFORMATION SU-6523MI Page 1 of 8 Table of Contents Page What is an HIV test?..........................................1 Will the HIV test tell me if I have AIDS?............................1
More informationPharmacy Plan Guidance
Pharmacy Plan Guidance The pharmacy plan is a tool used during the site readiness process to develop and document the site-specific procedures for study drug ordering, labeling and dispensing for the SHINE
More informationHOLY FAMILY CATHOLIC SCHOOL MEDICATION AND ASTHMA POLICY
HOLY FAMILY CATHOLIC SCHOOL MEDICATION AND ASTHMA POLICY Policy Statement - We would ask parents to request that their doctor, wherever possible, prescribe medication, which can be taken outside the school
More informationNORTH COLONIE 5422-R LIFE-THREATENING ALLERGIC REACTION (ANAPHYLAXIS) REGULATION ELEMENTARY LEVEL INFORMATION AND AWARENESS
LIFE-THREATENING ALLERGIC REACTION (ANAPHYLAXIS) REGULATION ELEMENTARY LEVEL INFORMATION AND AWARENESS 1. Identification of Anaphylactic Students to the District It is the responsibility of parents to
More informationChapter 9. Tests, Procedures, and Diagnosis Codes The McGraw-Hill Companies, Inc. All rights reserved.
Chapter 9 Tests, Procedures, and Diagnosis Codes Chapter 9 Content: Overview Ordering A Test SpringLabsTM & Reference Lab Results Managing and Charting Tests Creating A New Test Documenting and Activating
More informationProcedure Reviewed By: Narinder Sangha Deputy Chief Pharmacist STANDARD OPERATING PROCEDURE
Written By: Objective By: ed By: To ensure safe and consistent working practice throughout Black Country Partnership Foundation Trust (BCPFT) and to avoid unnecessary harm to patients on lithium therapy
More information5. Hospitals will provide the family with a copy of the Michigans Community Program: Information for Parents (MDCH /01). Copies can be ordered,
GUIDELINES FOR HEARING SCREENING A goal of newborn hearing screening is to ensure that all newborns receive a hearing screen before discharge from the hospital or before one month of age. All hospitals
More informationAppendix 11 Roles and Responsibilities October, 2013 Page 1 of 5
October, 2013 Page 1 of 5 Exposed Person To present to a health care facility as soon as possible following the exposure (ideally within 2 hours). To answer assessment questions. (Refer to Appendix 15
More informationNICU Glucose Management AKA The Insulin Protocol
NICU Glucose Management AKA The Insulin Protocol Laurie Love, APRN, CNP, CPS Jennifer Rivera, APRN, CNS Background Insulin causes about 10-12 cases of hypoglycemia per year in the NICUs at Children s,
More informationHelp Your Body Heal. Clinic Visits. After weight loss surgery
UW MEDICINE PATIENT EDUCATION Follow-up After weight loss surgery This section of the Guide to Your Weight Loss Surgery explains clinic visits and medical and other concerns in the weeks after surgery.
More informationSITUATION/BACKGROUND:
VCH Practice Alert KADIAN: a unique morphine long acting capsule Date: March 14, 2018 Site(s):VCH all sites SITUATION/BACKGROUND: Morphine long acting capsules are available in different formulations:
More informationStandard operating procedures for preparation and administration of intramuscular injections. No Action Rationale
Standard operating procedures for preparation and administration of intramuscular injections Preparation Overview No Action Rationale 1 Collect and check all equipment 2 Check that the packaging of all
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)
H GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH0-MGfa-H* (01/) H.B. Mar, HOUSE PRINCIPAL CLERK D Short Title: Strengthen Opioid Misuse Prevention (STOP)Act. (Public) Sponsors: Referred to:
More informationInstructions. 1. About how many babies are born or admitted to this hospital each year?
Instructions This questionnaire asks for information about hospitals* which use a systematic procedure for identifying newborns with hearing loss. In pilot-tests, respondents required an average of 18
More informationRecommended Component: Assure Immediate Access to Medications as Prescribed
Recommended Component: Assure Immediate Access to Medications as Prescribed Students must have immediate access to all medications as approved by healthcare providers and parents, regardless of the availability
More informationHIV MANAGEMENT PROGRAMME APPLICATION FORM
Private Private Bag X82081, Bag X82081, Rustenburg, Rustenburg, 0300 0300 Tel: Tel: (014) 590 5901700 1900 Fax: Fax: 086 (014) 577 0274 591 4570 www.platinumhealth.co.za www.platinumhealth.co.za ZZGPlatinumHealthClinicalMotivation@angloamerican.com
More informationPRESCRIBING SUPPORT TEAM AUDIT: ACE Inhibitors in the treatment of stable angina (October 2007) PRESCRIBING SUPPORT TECHNICIAN:
PRESCRIBING SUPPORT TEAM AUDIT: ACE Inhibitors in the treatment of stable angina (October 2007) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY SIGN Guideline No. 96 Management
More informationGood Practice Guidance on Covert Administration of Medication
Good Practice Guidance on Covert Administration of Medication This good practice guidance is intended to be used as a framework for care home managers and domiciliary care providers in drawing up their
More informationPoint of Care Testing. Bedside Glucose Meter
Point of Care Testing Bedside Glucose Meter 11/2017 Regulatory Overview Bedside glucose is a point of care lab test and YOU are performing this lab test under the Lab s CLIA license. All lab tests are
More informationMahoning County Public Health. Epidemiology Response Annex
Mahoning County Public Health Epidemiology Response Annex Created: May 2006 Updated: February 2015 Mahoning County Public Health Epidemiology Response Annex Table of Contents Epidemiology Response Document
More informationADMINISTRATION OF MEDICATIONS AT THE WALDORF SCHOOL OF PRINCETON
ADMINISTRATION OF MEDICATIONS AT THE WALDORF SCHOOL OF PRINCETON MEDICATION DURING SCHOOL HOURS Whenever possible, the parent/guardian should arrange with their physician for medication to be given outside
More informationManaging Continuity of Care through Integrated Care Pathways: A Study of Atrial Fibrillation and Congestive Heart Failure
Managing Continuity of Care through Integrated Care Pathways: A Study of Atrial Fibrillation and Congestive Heart Failure January 31, 2004 H. Jay Biem, MD, MSc Heather D. Hadjistavropoulos, PhD Funding
More informationMedical Documentation/Records. ADVERSE DRUG REACTIONS (ADRs) AND ALLERGIES TO MEDICATIONS
FLORIDA STATE HOSPITAL OPERATING PROCEDURE NO. 151-24 STATE OF FLORIDA DEPARTMENT OF CHILDREN AND FAMILIES CHATTAHOOCHEE, April 26, 2017 Medical Documentation/Records ADVERSE DRUG REACTIONS (ADRs) AND
More informationRefilling a Prescription with No Refills Remaining
................................................................................................... Refilling a Prescription with No Refills Remaining Pharmacy Technology Solutions May, 2013 Refilling
More informationHREC/17/RCHM/334 RCH HREC 37278A. ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank.
HREC Project Number: Research Project Title: Principal Researchers: HREC/17/RCHM/334 RCH HREC 37278A ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank. Associate Professor Justine
More informationNeedle Stick/Blood Borne Pathogen Exposure Guidelines
Needle Stick/Blood Borne Pathogen Exposure Guidelines Purpose: To outline the expected behavior to be followed by all student pharmacists who have received an accidental exposure incident while in an educational
More informationTexas Vendor Drug Program Specialty Drug List Process. February 2019
Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed
More informationUKALL14 DRUG SUPPLY GUIDELINES
CONTACT DETAILS UKALL14 DRUG SUPPLY GUIDELINES For further information on trial drugs, trial protocol, dosing, supply drug and distribution queries please contact: UKALL14 Trial Team Phone: 0207 679 9860
More informationHOW TO USE THE CLINICAL PATHWAY
1. 2. 3. 4. INCLUSION CRITERIA Primary admitting diagnosis is Congestive Heart Failure as defined by New York Heart Association. EXCLUSION CRITERIA Patients less than 19 years of age. HOW TO USE THE This
More informationMANAGEMENT OF NOISE AT WORK
MANAGEMENT OF NOISE AT WORK Version 01 / April 2015 Page 1 of 8 TSP/HS/011 This is a controlled document. It should not be altered in any way without the express permission of the author or their representative.
More informationGood Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes
Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes This good practice guidance is intended to be used as a framework for care home managers to adapt when writing their
More informationPOLICY All patients will be assessed for risk factors associated with OSA prior to any surgical procedures.
Revised Date: Page: 1 of 7 SCOPE All Pre-Admission Testing (PAT) and Same Day Surgery (SDS) nurses at HRMC. PURPOSE The purpose of this policy is to provide guidelines for identifying surgical patients
More informationCenter for Family Health Policy
Subject: Vaccine Management and Administration (Immunization) BOARD APPROVED: 7/30/96 REVISION APPROVED: 05/03/05, 04/08/08, 04/07/09, 04/12/11 Purpose: To ensure safe and appropriate storage, handling
More informationAUTHORIZATION FOR STUDENTS TO CARRY A PRESCRIPTION INHALER, EPINEPHRINE AUTO INJECTOR, INSULIN, AND DIABETIC SUPPLIES, OR OTHER APPROVED MEDICATION
AUTHORIZATION FOR STUDENTS TO CARRY A PRESCRIPTION INHALER, EPINEPHRINE AUTO INJECTOR, INSULIN, AND DIABETIC SUPPLIES, OR OTHER APPROVED MEDICATION needs to carry the following prescription labeled inhaler,
More informationURGENT UPDATED ADVICE ON DOSAGE OF OSELTAMIVIR IN CHILDREN UNDER ONE YEAR OF AGE WITH SWINE FLU
Primary and Community Care Directorate Pharmacy Division T: 0131-244 2518 F: 0131-244 2375 E: bill.scott@scotland.gsi.gov.uk 25 September 2009 abcdefghijklmnopqrstu = 1. Medical Directors NHS Boards 2.
More information4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP
New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6
More informationGuidance for Pharmacists on Safe Supply of Oral Methotrexate
Guidance for Pharmacists on Safe Supply of Oral Methotrexate Pharmaceutical Society of Ireland Version 2 January 2015 Contents 1. Introduction 2 2. Methotrexate 2 3. Guidance 2 3.1 Patient Review 2 3.2
More informationTAMPA ELECTRIC COMPANY ENERGY SUPPLY HEARING CONSERVATION PROGRAM
TABLE OF CONTENTS TITLE PAGE # PURPOSE / INTRODUCTION / SCOPE 1, 2 ROLES AND RESPONSIBILITIES 2 EMPLOYEE TRAINING 3 ENGINEERING CONTROLS 4 NOISE EXPOSURE EVALUATION 4 SIGNAGE / POSTING 4-5 AUDIOMETRIC
More informationEl Paso - Ambulatory Clinic Policy and Procedure
Regulation Reference: Title: NEEDLESTICK INJURIES/EXPOSURES TO BODY FLUIDS, CARE & FOLLOW UP Policy Number: EP 7.3 Effective Date: 6/2010 Policy Statement: A system is established and maintained to assure
More informationGuidance for the Network Review of Chemotherapy Errors
Guidance for the Network Review of Chemotherapy Errors For approvals and version control see Document Management Record on page 8 Doc Ref: AngCN-CCG-C31 Approved and published: March 2013 Page 1 of 8 Table
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW HOUSE BILL 243
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW 2017-74 HOUSE BILL 243 AN ACT STRENGTHENING OPIOID MISUSE PREVENTION BY EXTENDING STANDING ORDERS FOR OPIOID ANTAGONIST TO COMMUNITY HEALTH GROUPS;
More informationPatricia Bax, RN, MS August 17, Reaching New York State Tobacco Users through Opt-to-Quit
Patricia Bax, RN, MS August 17, 2015 Reaching New York State Tobacco Users through Opt-to-Quit Good Afternoon! Welcome Roswell Park Cessation Services and Opt-to-Quit Overview Featured Site: Stony Brook
More informationRESULTS REPORTING MANUAL. Hospital Births Newborn Screening Program June 2016
RESULTS REPORTING MANUAL Hospital Births Newborn Screening Program June 2016 CONTENTS GETTING STARTED... 1 Summary... 1 Logging In... 1 Access For New Hires... 2 Reporting Parental Refusals... 3 Adding
More informationBLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA
BLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan.
More informationWELCOME TO VIROQUA AREA SCHOOLS. Health Information Packet
WELCOME TO VIROQUA AREA SCHOOLS Health Information Packet Viroqua Area Schools HEALTH SERVICES 100 Blackhawk Drive Viroqua, WI 54665 Phone: (608) 637-1509 MS/HS, (608) 637-1103 Elementary Fax: (608) 637-8034
More informationIf viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.
If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Code: D: PC-5575 Entity: Fairview Pharmacy Services
More informationThe REDOXS Study. REducing Deaths due to OXidative Stress. A randomized trial of glutamine and antioxidant supplementation in critically ill patients
The REDOXS Study REducing Deaths due to OXidative Stress A randomized trial of glutamine and antioxidant supplementation in critically ill patients Pharmacy Manual This study is registered at Clinicaltrials.gov.
More informationconcentrate intravenous solution and other strong potassium solutions
Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous
More informationNORTHEAST HOSPITAL CORPORATION
NORTHEAST HOSPITAL CORPORATION Title: Influenza and Pneumococcal Immunization Date Effective: 11/04 Date Revised: 7/08, 2/6/12, 3/15/13; 9/13/13 Date Reviewed: Joint Commission Chapter: Provision of Care,
More informationPATIENT CARE MANUAL POLICY
PATIENT CARE MANUAL POLICY NUMBER #VII-F-20 PAGE 1 OF 2 APPROVED BY: CATEGORY: Senior Vice President, Medicine and Chief of Staff; Vice President and Senior Operating Officer, Covenant Health, Rural Health
More informationSpecifications Manual Update: Hospital Outpatient Quality Reporting (OQR) Program
Specifications Manual Update: Hospital Outpatient Quality Reporting (OQR) Program Melissa Thompson, RN, BSN Specifications Manual Lead Hospital OQR Program Support Contractor January 23, 2019 Featuring:
More informationVirginia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPOLICY, PRACTICE AND PROCEDURE ON ASTHMA IN THOMAS MORE CATHOLIC SCHOOL. Russell Hill Road, Purley, Surrey, CR8 2XP.
POLICY, PRACTICE AND PROCEDURE ON ASTHMA IN THOMAS MORE CATHOLIC SCHOOL Russell Hill Road, Purley, Surrey, CR8 2XP Mission Statement To Care for, respect and value all people and our environment. To Learn
More informationError Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS
Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS Medication Safety Officer OhioHealth Pharmacy Services Conflict of Interest Disclosure Kelly Besco declares no conflicts
More informationEssential Shared Care Agreement (South Staffordshire): Aciclovir Administration in the Community
E088 Essential Shared Care Agreement (South Staffordshire): Aciclovir Administration in the Community Patient s name: DOB NHS Number Patient s address: Consultant Note: Shared care agreement sets out a
More informationEnvironmental Health & Safety Policy Manual
Environmental Health & Safety Policy Manual Issue Date: 1/23/2014 Policy # EHS-400.14 Hearing Conservation Program 1.0 PURPOSE: To establish policy that defines the minimum requirements for the LSUHSC
More informationA three month project September December 2016
Improving Insulin Safety in the Clinical Decision Unit A three month project September December 2016 Sarah Gregory - In-Patient DSN, QEQM Hospital Julie Gammon - Ward Manager, CDU, QEQM Hospital 1 The
More informationQuality Performance Measurement and Use of Health Information Technology in Critical Access Hospitals
Quality Performance Measurement and Use of Health Information Technology in Critical Access Hospitals Michelle Casey University of Minnesota Rural Health Research Center Flex Monitoring Team 2006 National
More informationSUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure
SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure Subject: NEWBORN SCREENING FOR METABOLIC DEFICIENCIES Prepared By: Yolaine Henry Edit
More informationTalking with your doctors about palliative care Dr. Mary Anne Huggins and Barbara Pidcock
Talking with your doctors about palliative care Dr. Mary Anne Huggins and Barbara Pidcock You will have appointments with your family doctor, and with specialists. It will help you if you write your brief
More informationGuidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business
Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses
More informationAccommodations Request Severe Allergies Cover Sheet
Accommodations Request Severe Allergies Cover Sheet Child s Name: School Number: Director Name: School Phone #: Prospective Enrollment Date parent/guardian would like child to begin: Child Currently Enrolled
More informationNorth of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines
\ North of England Cancer Network Policies and Procedures Standards for the Safe Use of Oral Anticancer Medicines NECN Oral Anticancer medicine Policy version 1.6 Page 1 of 17 Issue Date: Feb 2017 Contents
More information